throbber
ARTICLE
`
`DOI: 10.1038/s41467-018-03432-4
`
`OPEN
`Structural basis for the recognition of LDL-receptor
`family members by VSV glycoprotein
`1, Laura Belot1, Hélène Raux1, Pierre Legrand
`2, Yves Gaudin
`1 & Aurélie A. Albertini1
`
`Jovan Nikolic
`
`Vesicular stomatitis virus (VSV) is an oncolytic rhabdovirus and its glycoprotein G is widely
`used to pseudotype other viruses for gene therapy. Low-density lipoprotein receptor (LDL-R)
`serves as a major entry receptor for VSV. Here we report two crystal structures of VSV G in
`complex with two distinct cysteine-rich domains (CR2 and CR3) of LDL-R, showing that their
`binding sites on G are identical. We identify two basic residues on G, which are essential for
`its interaction with CR2 and CR3. Mutating these residues abolishes VSV infectivity even
`though VSV can use alternative receptors, indicating that all VSV receptors are members of
`the LDL-R family. Collectively, our data suggest that VSV G has specifically evolved to
`interact with receptor CR domains. These structural insights into the interaction between
`VSV G and host cell receptors provide a basis for the design of recombinant viruses with an
`altered tropism.
`
`1234567890():,;
`
`1 Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198 Gif-sur-Yvette cedex, France. 2 Synchrotron
`SOLEIL, 91192 Gif-sur-Yvette cedex, France. These authors contributed equally: Jovan Nikolic, Laura Belot. Correspondence and requests for materials should
`be addressed to Y.G. (email: yves.gaudin@i2bc.paris-saclay.fr) or to A.Albertini. (email: aurelie.albertini@i2bc.paris-saclay.fr)
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`1
`
`Page 1 of 12
`
`KELONIA EXHIBIT 1018
`
`

`

`ARTICLE
`
`Vesicular stomatitis virus (VSV) is an enveloped, negative-
`
`strand RNA virus that belongs to the Vesiculovirus genus
`of the Rhabdovirus family. It is an arbovirus which can
`infect insects, cattle, horses, and pigs. In mammals, its ability to
`infect and kill tumor cells, although sparing normal cells makes it
`a promising oncolytic virus for the treatment of cancer1–3. VSV
`genome encodes five structural proteins among which a single-
`transmembrane glycoprotein (G). G plays a critical role during
`the initial steps of virus infection4. First, it is responsible for virus
`attachment to specific receptors. After binding, virions enter the
`cell by a clathrin-mediated endocytic pathway5,6. In the acidic
`
`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`the endocytic vesicle, G triggers the fusion
`environment of
`between the viral and endosomal membranes, which releases the
`genome in the cytosol for the subsequent steps of infection.
`Fusion is catalyzed by a low-pH-induced large structural transi-
`tion from a pre toward a post-fusion conformation, which are
`both trimeric7,8.
`The polypeptide chain of G ectodomain folds into three dis-
`tinct domains which are the fusion domain (FD), the pleckstrin
`homology domain (PHD), and the trimerization domain (TrD).
`During the structural transition, the FD, the PHD, and the TrD
`retain their tertiary structure. Nevertheless, they undergo large
`
`a
`
`sp
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`a
`
`cßb
`
`Ectodomain
`
`TM
`
`CR domains
`
`b
`GST-CR 1
`
`+ Gth pH 8
`2 3 4 5 6
`
`7
`
`GST
`
`O-link
`
`EGF
`c
`GST-CR
`
`+ Gth pH 8 + Gth pH 6
`1
`2 3
`1
`2 3
`
`d
`
`GST-CR
`
`+ VSV pH 8
`1
`2 3
`
`+ VSV pH 6
`1
`2 3
`
`L
`
`G N
`
`CRx-GST
`
`Gth
`
`CRx-GST
`GST
`
`75
`
`25
`
`75
`
`Gth
`
`CRx-GST
`
`25
`
`BSR
`
`Virus
`
`4 h
`
`or
`
`Anti VSV N
`GST-CRATTO550
`
`+VSVΔG-CHAV G
`
`f
`
`Anti N
`
`Microscopy
`
`+VSV
`
`GST-CR1ATTO550
`
`Merge
`
`Anti N
`
`GST-CR2ATTO550
`
`Merge
`
`Anti N
`
`GST-CR2ATTO550
`
`Merge
`
`75
`
`25
`
`e
`
`g
`
`Anti N
`
`GST-CR3ATTO550
`
`Merge
`
`Anti N
`
`GST-CR3ATTO550
`
`Merge
`
`Fig. 1 VSV G interacts specifically with CR2 and CR3 in its pre-fusion conformation. a Scheme of the modular organization of the LDL-R indicating the 7 CR
`modules (1–7), the 3 EGF repeats (a,b and c) , the seven-bladed β-propeller domain (β) of the epidermal growth factor precursor like domain (EGF), and the
`C-terminal domain containing O-linked oligosaccharides (O-link). SP signal peptide, TM transmembrane domain. b SDS–PAGE analysis of interaction
`experiments between the 7 GST-CR proteins, bound to GSH magnetic beads, and Gth at pH 8. c, d Coomassie-stained SDS–PAGE of interaction
`experiments between GST-CR1, GST-CR2 and GST-CR3, bound to GSH magnetic beads, and Gth (c) or VSV (d) at pH 8 and 6, respectively. Purified GST-
`CR bound to GSH magnetic beads were incubated with either Gth or VSV in the appropriate pH condition in presence of Ca2+ for 20 min at 4 °C. Then,
`after wash, the beads were directly loaded on a gel. As a control in b, GST alone bound to the GSH coated beads was incubated in presence of Gth.
`e Cartoon that illustrates the experiments presented in f and g. After 4 h of infection, BSR cells were labeled with an antibody directed against VSV
`nucleoprotein (anti-VSV N) to visualize the infection (green fluorescence) and a GST-CRATTO550 to probe CR domain recognition by the surface displayed
`glycoprotein (red fluorescence). f Labeling of G at the surface of BSR cells infected with VSV using fluorescent GST-CR1ATTO550, GST-CR2ATTO550, and
`GST-CR3ATTO550. At 4 h post-infection (p.i.), cells were incubated with the appropriate GST-CRATTO550 at 4 °C during 30 min prior fixation and
`permeabilization and then immuno-labeled using an anti-VSV N antibody to visualize the infection. g Labeling of CHAV G at the surface of BSR cells
`infected with a recombinant VSV expressing CHAV G (VSVΔG-CHAVG) using fluorescent GST-CR2ATTO550 and GST-CR3ATTO 550. Infected cells are
`labeled using anti-VSV N antibodies. In f and g, DAPI was used to stain the nuclei. Scale bars=20 µm
`
`2
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`Page 2 of 12
`
`

`

`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`ARTICLE
`
`CR1
`0
`
`10
`
`Time (min)
`20
`30
`40
`
`50
`
`60
`
`CR2
`0
`
`10
`
`Time (min)
`20
`30
`40
`
`50
`
`60
`
`CR3
`Time (min)
`0
`10 20 30 40 50
`
`60 70 80
`
`Kd=3.75 μM
`n = 0.8
`
`0.05
`
`0.00
`
`–0.05
`
`–0.10
`
`–0.15
`
`–0.20
`
`–0.25
`
`0.0
`
`–2.0
`
`–4.0
`
`–6.0
`
`μcal/s
`
`kcal mol–1 of injectant
`
`Kd=7.5 μM
`n = 1
`
`0.00
`
`–0.04
`
`–0.08
`
`–0.12
`0.0
`
`–1.0
`
`–2.0
`
`–3.0
`
`μcal/s
`
`kcal mol–1 of injectant
`
`0.0
`
`0.5
`
`1.0
`
`1.5
`
`2.0
`
`0.0
`
`0.5
`
`1.0
`
`1.5
`
`2.0
`
`2.5
`
`0.0
`
`0.5
`
`1.0
`
`1.5
`
`2.0
`
`2.5
`
`Molar ratio
`
`Molar ratio
`
`Molar ratio
`
`+VSVeGFP
`
`GST-CR1
`100 nM
`
`GST-CR2
`100 nM
`
`GST-CR3
`100 nM
`
`a
`
`0.20
`
`0.10
`
`0.00
`
`–0.10
`
`–0.20
`
`1.00
`
`0.50
`
`0.00
`
`μcal/s
`
`kcal mol–1 of injectant
`
`b
`
`CR1
`100 μM
`
`CR2
`100 μM
`
`CR3
`100 μM
`
`GST-CR2
`GST-CR3
`
`CR2
`CR3
`
`1
`
`4
`2
`3
`Receptor concentration (log nM)
`
`5
`
`6
`
`100
`
`50
`
`c
`
`% Neutralization
`
`0
`
`0
`
`Fig. 2 Characterization of VSV G-CR2 and VSV G-CR3 interaction a Isothermal titration calorimetry (ITC) analysis between Gth and CR1, Gth and CR2, Gth
`and CR3 at 20 °C. Representative plots of each ITC experiments are illustrated with raw data in the upper panel. Binding parameters were determined by
`curve fitting analysis with the single-site binding model. The values indicated in the panel are those corresponding to the curves that are presented. Kd
`values given in the text are means of three independent experiments±standard errors. b, c Inhibition of VSV infection by soluble forms of CR domains.
`b BSR cells were infected with VSV-eGFP preincubated with GST-CR1, GST-CR2, GST-CR3 (upper part), CR1, CR2, or CR3 monovalent domains (lower
`part) at the indicated concentrations. Cells were fixed 4 h p.i. Only infected cells are expressing eGFP. Note that neither CR1 nor GST-CR1 construction
`protect cells from infection. DAPI was used to stain the nuclei. Scale bars=100 µm. c VSV-eGFP was preincubated with increasing concentrations of GST-
`CR2, GST-CR3, CR2, or CR3 monovalent domains. At 4 h p.i., the percentage of infected cells was determined by counting the number of cells expressing
`eGFP using a flow cytometer. The percentage of neutralization was equal to 100 × [1−(% of infected cells in presence of CR)/(% of infected cells in the
`absence of CR domains)]. Data depict the mean with standard error for experiments performed in triplicate
`
`rearrangements in their relative orientation due to secondary
`changes in hinge segments (S1 to S5), which refold during the
`low-pH induced conformational change7–10.
`VSV G has been widely used for pseudotyping other viruses11–
`13 and VSV-G-pseudotyped lentiviruses (VSV-G-LVs) exhibit the
`same broad tropism as VSV. Recently it has been shown that low-
`density lipoprotein receptor (LDL-R) and other members of this
`receptor family serve as VSV receptors14. This result explains why
`VSV-G-LVs do not allow efficient gene transfer into unstimulated
`
`T cells, B cells, and hematopoietic stem cells, as they have a very
`low expression level of LDL-R15.
`The LDL-R is a type I transmembrane protein which regulates
`cholesterol homeostasis in mammalian cells16. LDL-R removes
`cholesterol carrying lipoproteins from plasma circulation. Ligands
`bound extracellularly by LDL-R at neutral pH are internalized
`and then released in the acidic environment of the endosomes
`leading to their subsequent lysosomal degradation. The receptor
`then recycles back to the cell surface. LDL-R ectodomain is
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`3
`
`Page 3 of 12
`
`

`

`ARTICLE
`
`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`a
`
`PHD
`
`b
`
`PHD
`
`N
`
`CR2
`
`S3
`
`S2
`
`C
`
`S1&S4
`
`TrD
`
`PHD
`
`S3
`
`N
`S2
`
`S5
`
`CR3
`
`N
`S3
`S2
`
`S4
`
`S1
`
`S5
`
`FD
`
`CTer
`
`CR2
`
`C
`
`TrD
`
`Top view
`
`FD
`
`CTer
`
`C
`
`S1&S4
`TrD
`
`S5
`
`PHD
`
`S3
`
`S2
`N
`
`CR3
`
`C
`
`TrD
`
`Top view
`
`S4
`
`S1
`S5
`
`c
`
`Side view
`
`PHD
`
`Y209
`
`TrD
`H8
`R354
`
`S2&S3
`
`K47
`
`Pre-fusion
`
`Side view
`e
`
`Viral membrane
`
`Viral membrane
`
`PHD
`
`S2&S3
`
`CR1
`CR2
`CR3
`
`CR4
`
`CR5
`
`CR6
`CR7
`
`CR1
`CR2
`CR3
`
`CR4
`
`CR5
`
`CR6
`CR7
`
`d
`
`TrD
`
`PHD
`
`Y209
`
`K47
`
`S2&S3
`
`TrD
`
`H8
`
`R354
`
`180°
`
`Post-fusion
`
`Cell membrane
`
`Cell membrane
`
`Fig. 3 X-ray structures of Gth-CR2 and Gth-CR3 complexes a, b Overview of GthCR2 (a) and Gth CR3 (b) crystalline structures in ribbon representation. G is
`depicted by domains and CR domains are in two shades of gray. The conserved disulfides bonds of each CR that maintain their secondary structure are in
`yellow. In both complexes the CR domain is nested in the same cavity of G. N and C-terminal extremities of each CR are indicated. Color code for Gth: the
`trimerization domain (TrD) is in red, the pleckstrin homology domain (PHD) is in orange, the fusion domain (FD) is in yellow. Those domains are connected
`by segments (S1 to S4) which refold during conformational change: segments S1 and S4 are in cyan, segments S2 and S3 are in green, S5 and the C-
`terminal segment (CTer) are in purple. The calcium ion of the CR domains is depicted as a green sphere. c Footprint of CR2 domain on G pre-fusion
`conformation. G is in full atoms view and depicted by domains. Residues of G that establish contacts with CR are shown in black on the surface of the
`protein. d Location of residues interacting with CR domains on G post-fusion conformation. Two views at 180° are shown. Note that the interaction patch is
`scattered when G is in this conformation. e Scheme showing the two complexes that can be formed between VSV G and LDL-R. At the cell surface, at
`neutral pH, the LDL-R adopts an open extended conformation19 and VSV G can bind either CR2 or CR3. Note that the LDL-R in this extended conformation
`has the appropriate orientation to interact with G anchored in the viral membrane
`
`composed of a ligand-binding domain, an epidermal growth
`factor (EGF) precursor homology domain and a C-terminal
`domain enriched in O-linked oligosaccharides. The ligand
`binding domain is made of 7 cysteine-rich repeats (CR1 to CR7,
`Fig. 1a and Supplementary Fig. 1). Each repeat is made of
`approximately 40 amino acids and contains 6 cysteine residues,
`engaged in 3 disulfide bridges, and an acidic residues cluster
`that coordinates a Ca2+
`ion17. The intracellular release of the
`cargo is driven by a low-pH-induced conformational change of
`LDL-R from an open to a closed conformation (Supplementary
`Fig. 1)17–19.
`The LDL-R gene family consists of trans-membrane receptors
`that reside on the cell-surface, are involved in endocytic uptake of
`lipoproteins, and require Ca2+
`for ligand binding. All these
`receptors have in common several CR repeats (up to several tens),
`EGF precursor-like repeats, a membrane-spanning region and an
`intracellular domain containing at least one internalization signal
`sequence20. They are found ubiquitously in all animals including
`insects21.
`
`Here we show that VSV G is able to independently bind two
`distinct CR domains (CR2 and CR3) of LDL-R and we report
`crystal structures of VSV G in complex with those domains. The
`structures reveal that the binding sites of CR2 and CR3 on G are
`identical. We show that HAP-1 cells in which the LDL-R gene has
`been knocked out are still susceptible to VSV infection con-
`firming that VSV G can use receptors other than LDL-R for entry.
`However, mutations of basic residues, which are key for inter-
`action with LDL-R CR domains, abolish VSV infectivity in
`mammalian, as well as insect cells. This indicates that the only
`receptors of VSV in mammalian and in insect cells are members
`of the LDL-R family and that VSV G has specifically evolved to
`interact with their CR domains.
`
`Results
`LDL-R CR2 and CR3 bind G and neutralize viral infectivity.
`We have expressed individually each LDL-R CR domain in fusion
`with the glutathione S-transferase (GST) in Escherichia coli.
`Proteins were solubilized in the presence of sarkosyl (acting as a
`
`4
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`Page 4 of 12
`
`

`

`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`ARTICLE
`
`a
`
`CR2 res 44–84
`CR3 res 85–123
`
`44
`
`85
`
`50
`
`90
`
`I
`
`70
`
`II
`
`IVIII
`80
`
`110
`
`120
`
`60
`
`100
`
`c
`
`b
`
`d
`
`K47
`
`Y209
`
`Q71
`
`II(D73)
`
`Y209
`
`D110
`
`K47
`
`II(D112)
`
`Ca2+
`
`R67
`
`C68
`
`H8
`
`I(D69)
`
`F65
`
`R354
`
`Ca2+
`
`I(D108)
`
`Q104
`
`H8
`
`V106
`C107
`
`R354
`
`e
`
`R354
`
`R354
`
`Ca2+
`
`Ca2+
`
`Y209
`
`K47
`
`H8
`
`W66
`
`A51
`
`Y209
`
`K47
`
`H8
`
`F105
`
`A51
`
`Fig. 4 Molecular basis of G/CR interaction. a Sequence alignment of LDL-R CR2 and CR3. Conserved residues are in a red box and similar residues are
`shown by red letters boxed in blue. Acidic residues involved in the binding of the Ca2+ ion are indicated by I, II, III, and IV. CR residues involved in polar
`contacts with G are labeled with gray symbols (light gray for CR2 and dark gray for CR3; dots when the contact is established via the lateral chain and
`triangles when the contact is established via the main chain) on each CR sequence. The aromatic residue which protrudes from the CR modules and
`establishes hydrophobic interactions with G is indicated by a blue arrow. b, c Close-up view on the Gth-CR interface showing the docking of G basic
`residues on the acidic patch of both CR2 (b) and CR3 (c). In both cases, the same G residues (H8, K47, Y209, and R354) are involved in the interaction.
`Residues labels on each CR domain are in italic letters when the contact is established via the main chain; putative bonds are shown as light blue dashed
`lines. d, e Close-up view on the Gth-CR interface showing the hydrophobic interactions between the aromatic residue W66 of CR2 (d) and F105 of CR3
`(e) and residues K47 and A51 of G.The color code is the same as in Fig. 3a and b
`
`mild denaturing agent), DTT and Ca2+ and renatured by dilution
`in a Ca2+
`containing buffer. The presence of Ca2+
`was manda-
`tory for correct folding of the proteins. Individual CR domains
`were then obtained by cleavage of the GST tag by prescission
`protease. All purified CR domains behave similarly in gel filtra-
`tion experiments (Supplementary Fig. 2).
`Each fusion protein was incubated at pH 8 with magnetic beads
`coated with glutathione before addition of a soluble form of the
`ectodomain of G (VSV Gth, amino acid (AA) residues 1–422,
`generated by thermolysin limited proteolysis of viral particles22)
`
`(Fig. 1b). After 20 min of incubation at 4 °C, the beads were
`washed and the associated proteins were analyzed by SDS/PAGE
`followed by Coomassie blue staining. This revealed that only CR2
`and CR3 domains are able to directly bind VSV G (Fig. 1b) at pH
`8. These results are consistent with previous data indicating that a
`monoclonal antibody (Mab) directed against LDL-R CR3 almost
`completely inhibited the VSV-triggered cytopathic effect which
`was not the case with a MAb directed against LDL-R CR614. The
`binding of Gth or VSV to fusion proteins GST-CR2 and GST-CR3
`was pH dependent and no interaction was detected at pH 6
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`5
`
`Page 5 of 12
`
`

`

`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`wt
`
`H8A
`
`0.5%
`
`80.1%
`
`0%
`
`83.5%
`
`0.1%
`
`Y209A
`87.0%
`
`K47A
`
`K47Q
`
`R354A
`
`R354Q
`
`0.1%
`
`42.6%
`
`0.2%
`
`7.7%
`
`0.3%
`
`4.4%
`
`0%
`
`2.6%
`
`13.8%
`
`0%
`
`5.5%
`
`0.2%
`
`16,2.7%
`
`0.8%
`
`12.0%
`
`93.4%
`
`0%
`
`96.0%
`
`0.4%
`
`96.1%
`
`2%
`
`0%
`
`45.7%
`
`2.8%
`
`89.3%
`
`11.5%
`
`3.2%
`
`0%
`
`0.7%
`
`0%
`
`83.7%
`
`0.7%
`
`0.3%
`
`0%
`
`97.1%
`
`0.3%
`
`94.1%
`
`0.4%
`
`99.3%
`
`ARTICLE
`
`CR2-GST
`
`a
`
`0.6%
`
`6%
`
`0.1%
`
`3.8%
`
`0.7%
`
`2.9%
`
`2.0%
`
`94.7%
`
`3.2%
`
`96.0%
`
`5.2%
`
`CR3-GST
`
`VSV G
`
`CR2
`CR3
`
`c
`
`VSV G
`
`P-GFP
`
`BSR
`
`or
`
`Transfection
`24 h
`
`Incubation
`at different pHs
`
`Empty
`
`wt
`
`H8A Y209A K47A K47Q R354A R354Q
`
`pH 5.5
`
`pH 6.0
`
`pH 6.5
`
`pH 7.0
`
`pH 5.5
`
`pH 6.0
`
`pH 6.5
`
`pH 7.0
`
`R354A
`
`K47Q
`
`R354Q
`
`Y209A
`
`b
`
`100
`
`80
`
`60
`
`40
`
`20
`
`0
`
`% labeled cells
`
`d
`
`Empty
`
`wt
`
`H8A
`
`K47A
`
`Fig. 5 K47 and R354 on G are crucial for interaction with CR domains but not required for fusion. a Flow cytometry analysis of the expression of WT and
`mutant glycoproteins at the surface of HEK293T cells and of the binding of fluorescent GST-CR2 (top) and GST-CR3 (bottom). After 24 h of transfection,
`cell surface expression of WT and mutant G was assessed using monoclonal anti-G antibody 8G5F11 directly on living cells at 4 °C during 1 h. Cells were
`then incubated simultaneously with anti-mouse Alexa fluor 488 and the indicated GST-CRATTO550. Cells transfected with a G construct that was still able
`to bind GST-CR proteins exhibited red fluorescence due the ATTO550 dye. In each plot, the percentage of ATTO550 positive cells is indicated. b WT and
`mutant G ability to bind CR domains. The histogram indicates the mean percentage of ATTO550 positive cells for each point mutation on G (n = 3). The
`error bars represent the standard deviation. c Cartoon describing the cell–cell fusion assay. BSR cells are co-transfected with plasmids expressing VSV G
`(either WT or mutant G) and P-GFP. After 24 h of post-transfection cells are exposed for 10 min to media adjusted to the indicated pH which is then
`replaced by DMEM at pH 7.4. The cells are then kept at 37 °C for 1 h before fixation. Upon fusion, the P-GFP diffuses in the syncytia. d Cell–cell fusion
`assay of WT and mutant glycoproteins. Scale bar=200 µm
`
`(Fig. 1c, d) suggesting that only G pre-fusion conformation is able
`to bind LDL-R. Finally, GST-CR2 and GST-CR3 (but not GST-
`CR1) fluorescently labeled with ATTO550 (Fig. 1e) specifically
`recognized VSV G expressed at the surface of infected cells but
`not
`the glycoprotein of Chandipura virus (CHAV, another
`vesiculovirus), which shares 40% AA identity with VSV G
`(Fig. 1f, g). We also used isothermal titration calorimetry (ITC) to
`investigate the binding parameters of CR1, CR2, and CR3 to Gth
`in solution (Fig. 2a). Here again, no interaction between Gth and
`CR1 was detected. On the other hand, for both CR2 and CR3, the
`binding
`reactions
`appear
`to
`be
`exothermic,
`show a
`
`1:1 stoichiometry and exhibit similar Kds in the micromolar
`range (4.3±1 µM for CR3 and 7.3±1.5 µM for CR2, mean±SEM of
`three independent experiments).
`Recombinant soluble CR2 and CR3 domains, either alone or in
`fusion with GST, are also able to neutralize viral infectivity when
`incubated with the viral inoculum prior infection (Fig. 2b). In
`order to determine the IC50 of the different constructions, we
`incubated 5 × 104 VSV-eGFP infectious particles with serial
`dilutions of GST-CR2, GST-CR3, CR2 or CR3. After 15 min,
`the mixtures were transferred onto 2 × 104 BSR cells for 30 min of
`adsorption. After 4 h,
`the percentage of
`infected cells (i.e.,
`
`6
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`Page 6 of 12
`
`

`

`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`ARTICLE
`
`n.s.
`
`n.s.
`n.s.
`
`*
`
`Ctrl
`+50 nM RAP
`
`*
`
`b
`
`1.0
`
`0.5
`
`Infectivity
`
`0.0
`
`H A P-1
`
`H A P-1
`LDL-RK O 1
`
`H A P-1
`LDL-RK O 2
`
`150
`
`100
`
`75
`
`50
`
`HAP-1
`
`HAP-1
`LDL-RKO1
`
`HAP-1
`LDL-RKO2
`
`HAP-1 LDL-RKO1
`LR P3
`LR P4
`LR P5
`LR P6
`
`LR P1
`
`LR P2
`
`LR P8
`
`SorLA
`
`vLDLR
`
`HAP-1 LDL-RKO2
`LR P4
`LR P5
`LR P6
`LR P8
`
`SorLA
`
`vLDLR
`
`LR P1
`
`LR P2
`
`LR P3
`
`a
`
`LDL-R
`
`Tub
`
`c
`
`600
`500
`400
`300
`200
`
`100
`
`Fig. 6 LDL-R presence on the cell surface is not mandatory for VSV infection. a Analysis of LDL-R expression in wild-type HAP-1, HAP-1 LDL-RKO1 and
`HAP-1 LDL-RKO2 cells. The immunoblot was performed on crude cell extracts and revealed with chicken anti LDL-R (GW22458A from Sigma). α-Tubulin
`(tub) was also immunoblotted as a loading control. The LDL-R band migrates with an apparent MW of 150 kDa due to the presence of glycosylation sites
`(predicted MW without oligosaccharides is 95 kDa). b Effect of the RAP protein on the susceptibility of LDL-R deficient HAP-1 cells to VSV-eGFP infection.
`VSV-eGFP was used to infect HAP-1 and HAP-1 LDL-RKO cells in the presence or not of RAP (50 nM). Infectivity was determined by counting the number
`of cells expressing eGFP using a flow cytometer. Data depict the mean with standard deviation for experiments performed in triplicate. p values were
`determined using an unpaired Student's t test (*p < 0.05; n.s. non-significant). c Expression of LDL-R family members in HAP-1 LDL-RKO cell lines evaluated
`by RT-PCR
`
`expressing the eGFP) was determined by flow cytometry. For
`both CR2 and CR3, the IC50 is about 15 µM and decreases to
`about 20 nM when fusion GST-CR constructions are used, thanks
`to their dimeric nature which induces avidity-enhanced binding
`to the viral glycoproteins (Fig. 2c).
`
`Crystal structures of Gth in complex with LDL-R CR domains.
`We crystallized Gth in complex with either CR2 or CR3. The
`crystal of the complex Gth-CR3 (diffracting up to 3.6 Å) belongs
`to space group P622. In this crystal form, the lattice organization
`of Gth molecules is identical to that of the crystal of Gth alone in
`pre-fusion state8 (Supplementary Fig. 3B). On the other hand, the
`Gth-CR2 crystal form (diffracting up to near 2.2 Å) belongs to the
`H32 space group (Supplementary Fig. 3A).
`The binding site of CR domains on G is the same in both
`crystal forms (Fig. 3a, b). CR2 (resp. CR3) interaction with G
`buries 1590 Å2 (resp. 1450 Å2) of the two molecules’ surfaces. It is
`essentially constituted by segments going from residues 8 to 10
`and 350 to 354 in the trimerization domain (TrD), 180 to 184 in
`the pleckstrin homology domain (PHD) and 47 to 50 in segment
`S2. Those three segments are rearranged in G post-fusion
`conformation7, which explains the inability of CR domains to
`bind G at low pH (Fig. 3c, d). It is worth noting that the
`orientation of CR domains in both complexes is optimal for the
`interaction between G and the open conformation of LDL-R
`when both proteins are anchored in their respective membranes
`(Fig. 3e).
`Two basic residues of G (H8 from the TrD and K47 from
`PHD) are pointing toward two acidic residues which belong to
`
`the octahedral calcium cage of the CR domains (D69 and D73 on
`CR2; D108 and D112 on CR3 labeled I and II—Fig. 4a). The side
`chain of K47 also establishes an H-bond with the amide group
`of Q71 (in CR2) and a salt bridge with the acidic group of D110
`(in CR3). Two other residues, Y209 (which makes hydrogen
`bonds with the C=O group of D69 on CR2, and with the C=O
`group of D108 and the carboxyl group of D110 on CR3) and
`R354 (which establishes contacts with the main chain of both
`CR domains), seem also to be key for the interaction (Fig. 4b,
`c). In both CR domains, the side chain of an aromatic residue
`(W66 in CR2 and F105 in CR3), which protrudes from the
`receptor module, also contributes to the stability of
`the
`complex by establishing hydrophobic interactions with the
`aliphatic part of K47 side chain and with the side chain of A51
`of G (Fig. 4d, e).
`
`K47 and R354 of G are crucial for LDL-R CR domains binding.
`To investigate their contribution to LDL-R CR domains binding,
`we mutated residues H8, K47, Y209, and R354 of G into an
`alanine or a glutamine. HEK cells were transfected with pCAGGS
`plasmids encoding wild-type or mutant VSV G glycoproteins
`(WT, H8A, K47A, K47Q, Y209A, R354A, and R354Q). After 24 h
`of post-transfection, the cells were incubated with MAb 8G5F11
`directed against G ectodomain. Then, green fluorescent anti IgG
`secondary antibodies and GST-CR proteins fluorescently labeled
`with ATTO550 were simultaneously added. Immunofluorescence
`labeling indicated that WT and all G mutants are efficiently
`transported to the cell surface (Fig. 5a). Mutants H8A and Y209A
`bind GST-CR proteins as WT G whereas the other mutants are
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`7
`
`Page 7 of 12
`
`

`

`ARTICLE
`
`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`affected in their binding ability (Fig. 5a, b). Mutants K47Q,
`R354A and R354Q bind neither GST-CR2 nor GST-CR3. Finally,
`although no interaction is detected between mutant K47A and
`CR3, a residual binding activity is observed between this mutant
`and CR2 (Fig. 5a, b).
`
`We also checked the fusion properties of all the mutants
`(Fig. 5c). For this, BSR cells were transfected with pCAGGS
`plasmids encoding wild-type or mutant VSV G glycoproteins.
`The cells expressing mutant G protein have a fusion phenotype
`similar to that of WT G (Fig. 5d). This confirms that the
`mutant glycoproteins are correctly folded and demonstrates
`
`a
`
`HEK
`
`VSV Gmut
`
`VSVΔG-GFP/VSV Gwt*
`
`24 h
`
`Infection
`
`16 h
`
`VSVΔG-GFP / VSV Gmut
`
`wt
`
`H8A
`
`K47A
`
`K47Q
`
`Y209A
`
`R354A
`
`R354Q
`
`BSR
`
`1
`
`1.3
`
`1.9
`
`2
`
`1.5
`
`1
`
`0.5
`
`0
`
`c
`
`Normalized G/M ratio
`
`17
`
`10
`
`9.6
`
`15
`
`471
`
`wt
`
`H8A
`
`K47A
`
`E m pty
`
`w T
`
`H8A
`
`K47A
`
`K47Q
`
`Y209A
`
`R354A
`
`R354Q
`
`G M
`
`1.0
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0.0
`
`Infectivity
`
`1
`
`HEK
`
`1.6
`
`3
`
`355
`
`84
`
`71
`
`116
`
`77
`
`wt
`
`H8A
`
`b
`kD
`
`250
`150
`100
`75
`
`50
`37
`25
`20
`15
`10
`
`d
`
`Infectivity
`
`1.0
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0.0
`
`E m pty
`
`K47A
`
`Y209A
`
`R354A
`
`K47Q
`
`R354Q
`
`E m pty
`
`Y209A
`
`R354A
`
`K47Q
`
`R354Q
`
`1
`
`S2
`
`5.6
`
`210
`
`E m pty
`
`15
`
`122
`
`wt
`
`H8A
`
`K47A
`
`*
`
`I
`
`II
`
`Y209A
`*
`
`87
`
`56
`
`76
`
`R354A
`
`K47Q
`
`R354Q
`
`IVIII
`
`*
`
`1.0
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0.0
`
`*
`
`Infectivity
`
`1
`
`1.5
`
`CHO
`
`1.9
`
`40
`
`28
`
`25
`
`25
`
`1188
`
`E m pty
`
`1.0
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0.0
`
`Infectivity
`
`e
`
`wt
`
`H8A
`
`K47A
`
`Y209A
`*
`
`R354A
`
`K47Q
`
`R354Q
`
`*
`
`LDLR CR2
`LDLR CR3
`
`47
`88
`
`VLDLR
`VLDLR
`LRP1
`LRP1
`LRP1B
`LRP2
`LRP2
`LRP2
`LRP3
`LRP4
`PGBM
`Vit. Rec
`
`33
`239
`3575
`3613
`967
`183
`1109
`1149
`455
`148
`285
`1283
`
`H H H H H H H H H H H H H
`
`D
`
`8
`
`NATURE COMMUNICATIONS | (2018) 9:1029
`
`| DOI: 10.1038/s41467-018-03432-4 | www.nature.com/naturecommunications
`
`Page 8 of 12
`
`

`

`NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03432-4
`
`ARTICLE
`
`that it is possible to uncouple G fusion activity and receptor
`recognition.
`
`Other LDL-R family members are alternative receptors of VSV.
`We infected two HAP-1 cell-lines (HAP-1 LDL-RKO1 and HAP-1
`LDL-RKO2) in which the LDL-R gene has been knocked out
`(Fig. 6a and Supplementary Fig. 4). Both were as susceptible to
`VSV infection as WT HAP-1 cells (Fig. 6b). This demonstrates
`that VSV receptors other than the LDL-R are present at the
`surface of HAP-1 cells.
`To evaluate the role of other LDL-R family members23 as VSV
`receptors, we took advantage of the properties of the receptor-
`associated protein (RAP), a common ligand of all LDL-R family
`members24–26 which blocks ligand binding to all LDL-R family
`members with the exception of LDL-R itself14,26. RAP signifi-
`cantly inhibits VSV infection in HAP-1 LDL-RKO cell lines but
`not in WT HAP-1 cells (Fig. 6b). Those results are consistent with
`previous data suggesting that VSV can use other LDL-R family
`members as alternative receptors14. Indeed, RT-PCR on purified
`RNA revealed the expression of several LDL-R family members
`including LRP1, LRP3, LRP4, LRP6, and sortilin (SorLA) in both
`HAP-1 LDL-RKO cell
`lines. Messengers corresponding to the
`vLDL-R were only detected in HAP-1 LDL-RKO2 (Fig. 6c).
`
`G mutants affected in CR binding cannot rescue VSVΔG-GFP.
`We then examined whether the mutant glycoproteins described
`above are able to sustain viral infection. We used a recombinant
`VSV (VSVΔG-GFP) in which the G envelope gene was replaced
`by the green fluorescent protein (GFP) gene and which was
`pseudotyped with the VSV G glycoprotein27,28. This pseudotyped
`recombinant was used to infect HEK cells either transfected or
`not transfected by a plasmid encoding WT or mutant glycopro-
`teins29. After 16 h, the infected cells supernatant was collected
`(Fig. 7a). Mutant glycoproteins incorporation into the envelope of
`the particles present in the supernatant was verified by western
`blot (Fig. 7b, c) and the infectivity of the pseudotyped particles
`was analyzed in different cell lines (mammalian HEK, BSR, CHO
`and Drosophila S2 cells) by counting the cells expressing GFP by
`flow cytometry 4 h p.i. (Fig. 7d). Mutants K47A, K47Q, R354A,
`and R354Q did not rescue the infectivity of VSVΔG-GFP.
`Compared to WT G, the infectivity decreased by a factor of 10 up
`to 120 (Fig. 7d). The decrease was more important in HEK and S2
`cell lines than in the two hamster cell lines. In mammalian cell
`lines, mutants H8A and Y209A can rescue the infectivity of
`VSVΔG-GFP at a level similar to that of WT. This is not the case
`in S2 cell line, where their infectivity significantly decreased (by a
`factor of 15 for mutant H8A and ~6 for Y209A) (Fig. 7d).
`
`As the fusion activity of the mutants is unaffected (Fig. 5d), the
`loss of infectivity of pseudotypes bearing a mutant glycoprotein
`can be safely attributed to their disability to recognize a cellular
`receptor. These results indicate that mutants K47A, K47Q,
`R354A, and R354Q which are unable to bind LDL-R CR domains
`are also severely impaired in their ability to bind other VSV
`receptors.
`
`Discussion
`LDL-R has been demonstrated to be the major entry port of VSV
`and lentivirus pseudotyped by VSV G14. Here, we demonstrate
`that VSV G is able to bind two CR domains of the LDL-R with
`similar affinities. The biological relevance of this interaction was
`demonstrated by the ability of both CR2 and CR3 to inhibit VSV
`infection. The crystal structures of VSV G in complex with CR2
`and CR3 reveal that they both occupy the same site at the surface
`of the glycoprotein in its pre-fusion conformation and that the
`same G residues ensure the correct anchoring of the CR domains.
`This binding site is split apart when G is in its post-fusion con-
`formation, which explains why G is unable to bind CR domains at
`low pH. This may disrupt the interaction between G and LDL-R
`in the acidic endosomal lumen and favor the transport of the
`virion to an appropriate fusion site.
`CR domain recognition by VSV G involves basic residues H8
`and K47, pointing toward the calcium-coordinating acidic resi-
`dues, and R354 which interacts with C=O groups of the main
`chain. This mode of binding is very similar to what is observed
`for endogenous ligand recognition by CR domains of the LDL-R
`family members17,30,31 and,
`indeed, mutant glycoproteins in
`which either K47 or R354 is replaced by an alanine or a gluta-
`mine, are unable to bind CR domains. It is worth noting that
`those key residues are not conserved among vesiculoviruses.
`Therefore, the use of LDL-R as a viral receptor cannot be gen-
`eralized to the other members of the genus. Indeed, we have
`shown that CHAV G, which does not possess basic residues in
`positions corresponding to VSV residues 47 and 354, does not
`bind CR domains.
`VSV G binds only CR2 and CR3. All CR domains have the
`same fold and all form a calcium cage involving conserved acidic
`residues. The acidic residues in position I and II, which play a key
`role in the interaction with G, are conserved except in CR7 which
`has an asparagine in position I (Supplementary Fig. 1). Therefore,
`they are poorly discriminant for the interaction between a given
`CR domain and G. Similarly, residue R354 of G interacts with the
`main chain of both CR2 and CR3 and the influence of CR
`domains amino acid sequence on this interaction is difficult to
`predict. However, the aromatic residues (W66 in CR2 and F105
`in CR3) establishing hydrophobic interactions with the aliphatic
`
`Fig. 7 Infectivity of VSVΔG-GFP virus pseudotyped with mutated G in vario

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket